PYC Therapeutics (ASX:PYC) has raised AU$133 million through its ongoing entitlement offer, part of a broader AU$146 million capital raise, according to a Wednesday filing with the Australian bourse.
The company expects to receive the remaining AU$13 million by April 30 after the underwriter for the outstanding balance has requested an extension citing liquidity issues, the filing said.
PYC is seeking payment guarantees and a bond from the underwriter to ensure the completion of the transaction, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.